Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hypnosis eases cancer procedure anxiety, small trial suggests

NCT ID NCT03755895

Symptom relief Sponsor: Institut de Cancérologie de Lorraine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Sep 02, 2026 · Updated 3 times

Summary

This completed Phase 2 trial tested whether formal hypnosis, alongside standard care, could reduce anxiety and pain in 68 cancer patients undergoing brachytherapy. Patients received either standard care with Kalinox or standard care plus formal hypnosis. The study measured anxiety using a standard questionnaire and pain with a numeric scale. The goal was to see if adding hypnosis improves patient comfort during the procedure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
formal hypnosis
What this could lead to
If it works, this could offer a drug-free way to ease anxiety and pain during brachytherapy, improving patient comfort.
What could go wrong
This is a small, Phase 2 trial with only 68 participants, so results may not apply to everyone. Hypnosis may not work for all patients, and the study is already completed, so no further development is planned.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

68 people

The number who actually took part.

Started

Nov 2019

Finished

May 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients ≥ 18 and ≤ 80 years * Patients expected to benefit a brachytherapy detachment Under KALINOX® for one of the types of applications described below: * Deep interstitial application: anal canal, vagina, vulva * Gynecological application: mold, Utrecht® system or Venezia® system * Ability to provide written informed consent * Patients affiliated to the social security system Exclusion Criteria: * Minor and patients over 80 years old * Patients with major hearing loss * Patients who had recent ocular surgery with oculiare gas injection. * Patients suffering from psychotic disorders, and dementias. * Patients who do not understand the French language * Patients under guardianship or deprived of liberty * Patients with a contraindication to the administration of KALINOX®

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Brachytherapy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer neoplasm prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Brachytherapy Cancer

Contacts and locations

Locations

  • Institut de Cancérologie de Lorraine

    Vandœuvre-lès-Nancy, 54519, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.